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Abstract Objective: To compare the
effects of He/O2 and external PEEP(PEEPe) on intrinsic PEEP (PEEPi),
respiratory mechanics, gas exchange,
and ventilation/perfusion (V.A/Q
. ) in
mechanically ventilated COPD pa-
tients. Design and setting: Prospec-
tive, interventional study in the in-
tensive care unit of a university hos-
pital. Interventions: Ten intubated,
sedated, paralyzed, mechanically
ventilated COPD patients studied in
the following conditions: (a) base-
line settings made by clinician in
charge, air/O2, ZEEP; (b) He/O2,
ZEEP; (c) air/O2, ZEEP; (d) air/O2,
PEEPe 80% of PEEPi. Measure-
ments at each condition included
V
.
A/Q
.
by the multiple inert gas elimi-
nation technique (MIGET). Results:
PEEPi and trapped gas volume were
comparably reduced by He/O2(4.2±4 vs. 7.7±4 cmH2O and 98±82
vs. 217±124 ml, respectively) and
PEEPe (4.4±1.3 vs. 7.8±3.6 cmH2O
and 120±107 vs. 216±115 ml, re-
spectively). He/O2 reduced inspirato-
ry and expiratory respiratory system
resistance (15.5±4.4 vs. 20.7±6.9
and 19±9 vs. 28.8±15 cmH2O l−1s−1,
respectively) and plateau pressure
(13±4 vs. 17±6 cmH2O). PEEPe in-
creased airway pressures, including
total PEEP, and elastance. PaO2/FIO2
was slightly reduced by He/O2(225±83 vs. 245±82) without signifi-
cant V
.
A/Q
.
change. Conclusions:
He/O2 and PEEPe comparably re-
duced PEEPi and trapped gas vol-
ume. However, He/O2 decreased air-
way resistance and intrathoracic
pressures, at a small cost in arterial
oxygenation. He/O2 could offer an
attractive option in COPD patients
with PEEPi/dynamic hyperinflation.
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Introduction
In mechanically ventilated patients with chronic obstruc-
tive pulmonary disease (COPD), incomplete exhalation
of inspired tidal volume (VT) due to elevated airway re-
sistance and decreased lung elastic recoil can lead to an
increase in end-expiratory lung volume, termed “dynamic
hyperinflation” [1, 2] or “intrinsic” positive end-expirato-
ry pressure (PEEPi) [3, 4]. The numerous deleterious ef-
fects of PEEPi on respiratory mechanics, gas exchange,
hemodynamics, oxygen transport, and work of breathing
[3, 4, 5] can be attenuated by measures aimed at reducing
dynamic hyperinflation, such as reduction in VT and res-
piratory rate [6], bronchodilators [7], and applying exter-
nal PEEP (PEEPe) [8]. However, the latter is difficult to
titrate [4] and may by itself be detrimental by increasing
lung volumes and intrathoracic pressures [9, 10], and
worsening of hemodynamics [9, 11]. Alternatively, re-
placing the inhaled air-oxygen mixture by helium-oxy-
gen, which reduces resistance to flow in the airways [12]
P. Jolliet (✉) · D. Tassaux
Medical Intensive Care Division,
University Hospital,
1211 Geneva 14, Switzerland
e-mail: jolliet@medecine.unige.ch
Tel.: +41-22-3729093
Fax: +41-22-3729105
C. Watremez · J. C. Ngengiyumva
M. de Kock
Division of Anesthesiology,
Clinique Universitaire St.-Luc,
Brussels, Belgium
J. Roeseler · M. Reynaert
Departement of Emergency 
and Intensive Care,
Clinique Universitaire St.-Luc,
Brussels, Belgium
T. Clerbaux · B. Detry · G. Liistro
Division of Pneumology,
Clinique Universitaire St.-Luc,
Brussels, Belgium
D. Tassaux
Division of Anesthesiology,
University Hospital,
1211 Geneva 14, Switzerland
1443
due to its low density, has been shown to decrease PEEPi
and trapped gas volume [13]. However, He/O2 also raises
concerns, among which are interference with ventilator
function [14] and worsening of hypoxemia, the latter hav-
ing been documented in spontaneously breathing COPD
patients [15, 16]. The purpose of this study was thus to
compare the effects of He/O2 and PEEPe on PEEPi, res-
piratory mechanics, gas exchange, and ventilation/perfu-
sion (V.A/Q
.) in mechanically ventilated COPD patients.
Methods
Patients
The study was conducted in the Division of Intensive Care, St.-
Luc Hospital, Brussels. Intubated patients consecutively admitted
to the ICU were included if they met diagnostic criteria of COPD
[17] and had been mechanically ventilated for no longer than 48 h.
Patients were excluded if pneumothorax was present or the in-
spired O2 fraction (FIO2) was 0.4 or higher. The study included
ten patients (aged 64±9 years) after a mean of 28±5 h of mechani-
cal ventilation. Individual baseline characteristics, main ventilator
settings, PEEPi measurement and arterial blood gases of the pa-
tients are summarized in Table 1. The study protocol was ap-
proved by the ethics committee of the Catholic University of Lou-
vain, Brussels. Consent was obtained from next of kin.
Procedures and measurement techniques
Patients were sedated and paralyzed by a continuous infusion of
propofol or midazolam, and vecuronium or atracurium. All pa-
tients were ventilated with a Siemens Servo 300 (Siemens-Elema,
Solna, Sweden) which is easily compatible with the use of helium
[14]. Helium was delivered from a 50-l canister containing a
78:22 mixture of He and O2, pressurized at 200 bar, through a
pressure regulator at 6 bar into the ventilator’s air inlet [18]. Ven-
tilator mode was volume-controlled pressure limited ventilation.
Set VT was not corrected for He/O2 since on the machine used
the change in density does not affect delivered VT, while expired
VT (VTe) readings were corrected using appropriate factors [14].
As a final precaution VTe was monitored with a density-indepen-
dent spirometer (5420 Volume Monitor, Ohmeda, Louisville,
Col., USA).
During the entire protocol, the FIO2 and ventilator settings
made by the clinician in charge of the patient before inclusion
were kept constant. Maximum pressure limit was set at
40 cmH2O. Inspiratory flow rate was 60 l/min, square wave flow
pattern. No PEEP was set on the ventilator except during the last
step of the study at which time an PEEPe of 80% of PEEPi mea-
sured at air/O2 zero end-expiratory pressure (ZEEP) 2 was applied(see below).
Respiratory rate, airway pressure, flow, and inspiratory:expira-
tory (I:E) ratio were recorded from the ventilator. Respiratory
system static elastance (Ers) and inspiratory (Rinsp) and expiratory(Rexp) resistances were computed by the automatic measuring al-
gorithms of the ventilator after a brief end-inspiratory pause. PE-
EPi was measured by an end-expiratory occlusion [3], also per-
formed automatically on the Servo 300. This end-expiratory oc-
clusion technique actually measures total PEEP in static condi-
tions. Therefore when no PEEPe is applied, the readout is equiva-
lent to the value of PEEPi, whereas when PEEPe is applied, PE-
EPi is equal to the value of total PEEP (PEEPtot) obtained by end-
expiratory occlusion minus that of PEEPe set on the ventilator [4,
19]. For each set of measurements the end-expiratory occlusion
was performed three times at 1-min intervals and PEEPi reported
as the mean of the three readings. End-expiratory trapped lung
volume (Vtrapped) was determined by the end-inspiratory apnea
technique [6]. Briefly, the patient was disconnected from the ven-
tilator at end-inspiration, and the total exhaled volume measured
with the spirometer, until expiratory flow was no longer detect-
able. Total exhaled volume represents total end-inspiratory volume
(VEI) above functional residual capacity. Vtrapped at end-expiration
was then computed as: Vtrapped=VEI−measured VT. Measured VT
was determined as the mean of the last five breaths before the ma-
neuver [6].
Heart rate and mean systemic arterial pressure were continu-
ously monitored by standard three-lead monitoring electrodes and
an indwelling arterial catheter, respectively. Arterial oxygen satu-
ration was continuously monitored by pulse oximetry.
Ventilation-perfusion relationships 
by the multiple inert gas elimination technique
The distribution of the V
.
A/Q
.
values was assessed by the multiple
inert gas elimination technique (MIGET) [20]. Briefly, six inert
gases of varying solubility (SF6, ethane, cyclopropane, halo-
thane, ether, and acetone) were equilibrated in 0.9% NaCl and
were infused at a constant rate of 3 ml/min through the central
venous line. After a 30-min equilibration period 10 ml blood
Table 1 Patients’ baseline characteristics (PEEPi intrinsic positive end-expiratory pressure, RR respiratory rate, VT tidal volume,
Vtrapped volume of gas trapped in the lungs at end-expiration)
Patient no Age RR VT Vtrapped PEEPi FIO2 PaO2/FIO2 PaCO2(years) (n/min) (ml) (ml) (cmH2O) (mmHg)
1 55 13 590 110 7 0.40 313 46
2 80 16 365 150 16 0.38 200 62
3 64 16 494 490 12 0.30 190 53
4 76 12 330 150 2 0.31 255 42
5 68 12 503 190 5 0.30 307 48
6 53 12 327 120 5 0.25 340 46
7 64 11 496 110 4 0.30 366 43
8 50 22 328 350 8 0.40 116 72
9 68 12 560 210 9 0.40 175 49
10 65 16 430 290 9 0.35 191 49
Mean 64 14.5 442 217 7.7 0.35 245 51
SD 9 3 100 125 4.1 0.07 82 9
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samples from the peripheral artery and 5 ml blood samples from
the pulmonary artery catheter, if present, or the central venous
line were withdrawn into 20-ml heparinized glass syringes. Cen-
tral venous sampling is an acceptable alternative in the absence
of a pulmonary artery catheter [21]. Samples of mixed expired
gas were collected from the exhaust port of the ventilator into
50 ml gas-tight syringes (Hamilton 50 TLL, Hamilton, Reno,
Nev., USA). A gas chromatograph (Perkin Elmer, Shelton Conn.,
USA) equipped with an electron capture detector for SF6 and a
flame ionization detector for the other five gases was used to de-
termine the inert gas concentrations. Retention (ratio of arterial
to mixed venous concentration) and excretion (ratio of mixed ex-
pired air to mixed venous concentration) were computed for each
gas. The continuous distribution of blood flow and ventilation
against the ventilation-perfusion ratios from these data were 
calculated by the computer program developed by Evans and
Wagner [22]. Disp R-E*, an overall index of V.A/Q
.
heterogeneity,
was also determined. The residual sum of squares, a quantitative
estimation of the overall experimental error in the procedure, was
computed [23]. In high-quality measurements the residual sum of
squares between the measured and calculated V
.
A/Q
.
distributions
should be less than 5.3 in 50% and less than 10.6 in 90% of all
data sets [23].
Cardiac output and oxygen transport
If a pulmonary artery catheter was in place, cardiac output was de-
termined by thermodilution. In the absence of such a catheter, car-
diac output was estimated by the Fick method, using central ve-
nous rather than mixed venous blood samples. Oxygen transport
(D. O2) was computed according to standard equations. Oxygen
consumption (V. O2) was determined from the inspired-expired O2
concentrations.
Measurement protocol
A complete set of all measurements was performed at the follow-
ing time points: (a) upon starting the protocol, no PEEPe (air/O2
ZEEP1); (b) after 30 min of He/O2 inhalation, no PEEPe (He/O2
ZEEP); (c) after 30 min of air/O2 inhalation, no PEEPe (air/O2
ZEEP 2); (d) after 30 min of air/O2 inhalation, PEEPe, set as 80%
of PEEPi measured at air/O2 ZEEP 2 (air/O2 PEEPe). The mean
level of PEEP applied at air/O2 PEEPe was 6.4±4 cmH2O.
Statistical methods
Values are reported as mean ±standard deviation. One-way analy-
sis of variance for repeated measures was used to compare the val-
ues obtained at each of the four conditions. Significance between
time points was determined by Fisher’s protected least signifi-
cance test. A p value less than 0.05 was considered significant.
Fig. 1 Intrinsic PEEP and trapped gas volume. Individual values
of trapped gas volume (Vtrapped, left) and intrinsic PEEP (PEEPi,
right) under all conditions tested. Air/O2 ZEEP 1 Initial settings
made by clinician, no PEEP; He/O2 ZEEP after 30 min of He/O2
inhalation, no PEEPe; air/O2 ZEEP 2 after 30 min of air/O2 inha-
lation, no PEEP; air/O2 PEEPe after 30 min of air/O2 inhalation,
PEEPe 80% of PEEPi measured at air/O2 ZEEP 2
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Results
Ventilatory parameters PEEPi and respiratory mechanics
As shown in Table 2, He/O2 led to a significant reduction
in peak (PIP) and plateau (Pplat) pressures, Ers, and both
Rinsp and Rexp. Conversely, PEEPe significantly increased
mean airway pressure and Pplat, while there was a trend to-
wards a rise in PIP and Ers. Rinsp and Rexp were not signif-
icantly affected by PEEPe. Vtrapped and PEEPi were both
comparably reduced by He/O2 and PEEPe (Table 2), this
response being present in all patients, as shown in Fig. 1.
Fig. 2 Total and external PEEP. Individual measured levels of to-
tal PEEP (PEEPtot), determined by the end-expiratory occlusion
technique, during He/O2 inhalation (A, left) and external PEEP(PEEPe) application (B, right). A Magnitude of PEEPtot (i.e., in-
trinsic PEEP, since no PEEPe was applied) during air/O2 (white
bars) and He/O2 (black bars) inhalation. B Magnitude of PEEPtot
with air/O2 and ZEEP (white bars), and air/O2 and PEEPe applica-
tion, partitioned into PEEPi (black area) and PEEPe (hatched 
area) components
Table 2 Ventilatory parameters (Ers elastance of the respiratory
system, PEEPi intrinsic positive end-expiratory pressure, PIP
peak inspiratory pressure, Paw airway pressure, Pplat plateau pres-
sure, Rinsp inspiratory respiratory system resistance, Rexp expiratory 
respiratory system resistance, Vtrapped trapped lung volume at end-
expiration)
Air/O2 ZEEP1 He/O2 ZEEP Air/O2 ZEEP2 Air/O2 PEEPe
Respiratory rate (n/min) 14±2.5 14±2.4 14±2 14±2.6
VTe (ml) 442±100 410±154 427±130 449±100
PIP (cmH2O) 29±9 23.5±8* 28.4±9 29.3±9
Paw mean (cmH2O) 7.8±3 6.4±3 8.1±3.4 11.3±4**
Pplat (cmH2O) 17±6 13±4* 16±6 19±7***
Ers (cmH2O l−1) 23.8±8 17.4±7* 23.3±9 25.6±10
Rinsp (cmH2O l−1 s−1) 20.7±6.9 15.5±4.4* 21.2±5.9 19.5±4.4
Rexp (cmH2O l−1 s−1) 28.8±15 19±94* 29.6±14 22.1±11
PEEPi (cmH2O) 7.7±4 4.2±44* 7.8±3.6 4.4±1.34*
Vtrapped (ml) 217±124 98±824* 216±115 120±1074*
*p<0.001 vs. air/O2ZEEP 1, ZEEP 2 and air/O2 PEEPe, **p<0.01 vs. air/O2 ZEEP 1, ZEEP 2 and He/O2ZEEP, ***p<0.05 vs.
air/O2ZEEP 2, 4*p<0.001 vs. air/O2ZEEP 1 and ZEEP 2 (analysis of variance)
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However, PEEPtot differed markedly between these two
conditions (Fig. 2). With He/O2, as expected, since PEEPi
was reduced in all patients and no PEEPe was applied,
PEEPtot was also decreased in all patients. With PEEPe,
even though PEEPi decreased in all patients, PEEPtot de-
creased in only two (patients 5 and 7), was unchanged in
three (patients 1, 6, and 9), and increased in five (patients
2, 3, 4, 8, and 10), as shown in Fig. 2.
Arterial blood gases and V
.
A/Q
.
relationships
No significant modification in arterial pH or arterial
blood gases was observed during the study, with the ex-
ception of a decrease in arterial oxygenation during
He/O2 inhalation (Table 3). MIGET analysis (Table 4)
showed a small shunt at baseline, with most of the perfu-
sion directed to areas of intermediate or normal V
.
A/Q
.
. A
high deadspace fraction was present at baseline, the re-
maining ventilation being distributed mainly to areas of
intermediate or normal V
.
A/Q
.
. He/O2 exerted little change
on V
.
A/Q
.
relationships. No significant V
.
A/Q
.
modification
was observed with PEEPe. MIGET tracings from a typi-
cal patient are shown in Fig. 3. V
.
A/Q
.
heterogeneity,
quantified by the Disp R-E* index, was not significantly
modified by either He/O2 or PEEPe (Table 4). Mean
overall residual sum of squares was 3.02±1.84, and was
less than 5.3 in 80% of data sets, well within the range of
high technical quality measurements [23].
Hemodynamics and oxygen transport
No significant changes in arterial blood pressure, heart
rate D
.
O2, or V
.
O2 were noted during the various phases
of the study (Table 3)
Table 3 Hemodynamics, 
arterial blood gases 
and oxygen transport 
(DA-aO2 alveoloarterial O2
difference, D
.
O2 O2 transport,
MAP mean systemic arterial
pressure, V
.
O2 O2 consumption,
O2ER O2 extraction ratio)
Air/O2 ZEEP 1 He/O2 ZEEP Air/O2 ZEEP 2 Air/O2 PEEPe
Heart rate (n/min) 83±19 82±18 84±17 84±19
MAP (mmHg) 76±11 79±8 83±12 81±14
Cardiac output (l/min) 6.50±3.7 6.99±4.07 6.91±3.66 6.45±3.28
pH 7.29±.04 7.27±.05 7.27±.03 7.28±.06
PaO2 (mmHg) 81±21 74±4* 80±19 86±7
PaO2/FIO2 245±82 225±83* 238±67 252±68
DA-aO2 (mmHg) 96±49 99±48 98±48 96±47
PaCO2 (mmHg) 51±9 53±11 51±7 50±6
D
.
O2 (ml/min) 835±159 865±123 876±172 837±164
V
.
O2 (ml/min) 170±72 176±83 162±56 166±65
O2 ER 0.21±0.09 0.22±0.10 0.19±0.08 0.21±0.11
*p<0.01 vs. air/O2 ZEEP 1 
and air/O2 PEEP (analysis of variance)
Table 4 Results of multiple in-
ert gas elimination technique
(DISP R-E* index of dispersion
of ventilation/perfusion ratios,
corrected for deadspace, RSS
residual sum of squares, %Q.T
percentage of pulmonary blood
flow,V
.
A/Q
.
ventilation to perfu-
sion ratio, % VE percentage of
minute ventilation, Log SD Q.
log standard deviation of perfu-
sion, LogSD V
.
log standard de-
viation of ventilation distribu-
tion)
Air/O2 ZEEP1 He/O2 ZEEP Air/O2 ZEEP2 Air/O2 PEEPe
Perfusion
Shunt (% Q. T) 6.8±10 7.5±12.2 5.9±10.3 7.7±13.6
0.005<V
.
A/Q
.
<0.01 (% Q. T) 4.4±6.1 4.1±4.7 4.1±3.9 2.7±2.5
0.01<V
.
A/Q
.
<0.1 (% Q. T) 15.8±10.6 23.7±12.7 23.4±14.9 17.2±14.1
0.1<V
.
A/Q
.
<1 (% Q. T) 62.1±18 56.4±18.7 57.1±18.2 61.3±17.8
1<V
.
A/Q
.
<10 (% Q. T) 10.9±8.8 8.3±8.1 9.5±9.2 11.1±9.8
10<V
.
A/Q
.
<100 (% Q. T) 0.05±0.08 0.07±0.13 0.00±0.00 0.02±0.06
Mean Q. (l/min) 0.27±0.12 0.20±0.09* 0.21±0.09 0.27±0.11
Log SD Q. 1.34±0.33 1.44±0.33 1.42±0.31 1.31±0.28
Ventilation
Deadspace (% VE) 64.9±8.4 66.3±7.6 65.2±9.0 65.4±8.1
0.005<V
.
A/Q
.
<0.01 (% VE) 0.02±0.04 0.03±0.05 0.02±0.04 0.01±0.03
0.01<V
.
A/Q
.
<0.1 (% VE) 0.5±0.4 1.0±0.8 0.8±0.6 0.6±0.6
0.1<V
.
A/Q
.
<1 (% VE) 19.9±.71 18.7±5.5 20.7±7.1 20.2±6.9
1<V
.
A/Q
.
<10 (%VE) 14.3±7.2 13.75±7.6 13.2±6.9 13.6±7.1
10<V
.
A/Q
.
<100 (% VE) 0.43±0.71 0.57±1.03 0.00±0.00 0.02±0.06
Mean V
.
A (l/min) 0.99±0.36 0.95±0.22 0.84±0.25 0.88±0.36
Log SD V
.
1.0±0.26 1.08±0.24 0.97±0.22 0.89±0.30
RSS 2.61±1.92 3.92±2.39 3.23±1.75 2.31±0.80
Disp R-E* 17.6±10.2 21.9±7.9 19.2±7.7 18±8.8
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Complications
No complication occurred during any of the protocol
phases.
Discussion
The main findings of this study in a group of sedated,
paralyzed, and mechanically ventilated COPD patients
with moderate levels of PEEPi are that He/O2 reduced
PEEPi and Vtrapped, airway pressures and resistances, and
elastance at a small cost in arterial oxygenation. Con-
versely, PEEPe set at 80% of measured PEEPi, reduced
PEEPi and Vtrapped but increased airway pressures and in
most patients PEEPtot. Neither approach significantly
affected V
.
A/Q
.
distribution.
Effects of He/O2
The observed effects of He/O2 on PEEPi and respiratory
mechanics are consistent with those documented in a
previous study in intubated, sedated, paralyzed patients
undergoing controlled mechanical ventilation, with com-
parable levels of PEEPi, in which He/O2 led to a marked
decrease in Vtrapped and PEEPi in 22/23 patients [13].
The concordant results from the two studies, with effects
observed in almost every patient, provides further evi-
dence that He/O2, due to its low density and resultant re-
duction in airway resistance, effectively attenuates dy-
namic hyperinflation/PEEPi in this setting. It should be
noted nonetheless that He/O2 has no impact on the cause
of obstructive disease and airflow limitation. Thus its ef-
fects disappear once its administration is discontinued,
as shown by the rapid return to baseline values of PEEPi
and Vtrapped in both our studies when He/O2 inhalation
was stopped. Consequently the use of He/O2 should not
deter ICU physicians from aiming to decrease airway ob-
struction with bronchodilating drugs, and avoiding ex-
cessive respiratory rate and VT settings on the ventilator
[4]. Among concerns regarding the use of He/O2 in
Fig. 3 MIGET evaluation of V
.
A/Q
.
relationships. Representative
MIGET tracings obtained in the four study conditions in one 
patient. White dots Ventilation; black dots perfusion; S shunt; Ds
deadspace
COPD patients is a possible worsening of arterial oxy-
genation, documented in studies performed in spontane-
ously breathing nondecompensated patients [15, 16]. In
one study He/O2 breathing entailed a decrease in PaO2,
hypothesized to result from an increase in the heteroge-
neity of V
.
A/Q
.
distribution [16]. Another study document-
ed an increase in the alveoloarterial O2 gradient during
He/O2 inhalation [15]. MIGET analysis was consistent
with a diffusion impairment for O2, attributed by the au-
thors to a proximal displacement of the transition from
convective to diffusive gas transfer processes [15, 24].
Finally, a slight decrease in PaO2 with He/O2 compared
to air/O2 was also noted in a study by Christopherson
and Hlastala [25], in mechanically ventilated dogs, with-
out significant change in MIGET results, and also attrib-
uted by the authors to displacement of the convec-
tive/diffusive front in the airways [15, 24, 25]. However,
whether these results can be extrapolated to decompen-
sated and mechanically ventilated patients is unclear
since in a previous study on patients undergoing me-
chanical ventilation we found no impact of He/O2 on ar-
terial oxygenation [13]. It should also be noted that a de-
crease in alveolar ventilation, suggested by the slight rise
in PaCO2 with He/O2, could also have contributed in the
decrease in PaO2.
Our MIGET results are in line with these observations.
Overall the baseline pattern of a small fraction of shunt
and perfusion to low V
.
A/Q
.
regions, perfusion predominat-
ing in regions of V
.
A/Q
.
=1, and high deadspace (Table 4) is
consistent with both the so-called “H” pattern described
by Wagner et al. [26] in stable spontaneously breathing
patients with severe COPD and the profile found in two
studies in COPD patients during controlled mechanical
ventilation [8, 27]. In our study no significant change was
observed with He/O2, thus excluding a major effect of
He/O2 on shunt, low V
.
A/Q
.
or worsening of V
.
A/Q
.
inequali-
ty. The convective/diffusion front theory mentioned above
could explain these results [24], the small magnitude of
worsening hypoxemia being in line with that observed in
other studies [15, 25]. Indeed, the magnitude of worsening
of hypoxemia was small (8%) and is probably of negligi-
ble clinical importance in patients receiving a mean FIO2
of 0.35. Why these findings differed from those of our
preceding study [13] in a comparable patient population
and setting is not immediately clear. However, in the earli-
er study patients were ventilated for 45 min with He/O2,
compared to the 30 min in the present study, possibly al-
lowing any time-dependent short-term V
.
A/Q
.
heterogeneity
to subside. Furthermore, there was a trend towards a de-
crease in PaO2 in the former study with He/O2, by 6%, al-
though the difference was not statistically significant [13].
Of importance, and in the same line of thought, no wors-
ening of hypoxemia was noted during noninvasive pres-
sure support with He/O2 in decompensated COPD patients
in two recent studies [18, 28]. Finally, a recent study on
the impact of various inspiratory flow waveforms in me-
chanically ventilated COPD patients demonstrated that
square wave inspiratory flow as used in the present study
was less favorable on gas exchange than decelerating flow
[29]. This factor might have contributed to our results. To
summarize, it seems that a reduction in PaO2 during
He/O2 inhalation in this setting is either absent or of very
small magnitude and probably represents a minor price to
pay for the major beneficial effects on dynamic hyperin-
flation and respiratory mechanics.
Regarding PaCO2, the absence of change with He/O2
was somewhat surprising, given that two studies using
noninvasive ventilation documented a reduction in
PaCO2 with He/O2, possibly due to improved CO2 diffu-
sion [18, 28]. However, the results are in accord with
those of our previous study in intubated and mechanical-
ly ventilated patients [13] and are in line with the ab-
sence of change in the V
.
A/Q
.
results, in particular dead-
space (Table 4).
Effects of PEEPe
In patients with PEEPi undergoing spontaneous/assisted
mechanical ventilation, applying PEEPe has been shown
to reduce the inspiratory threshold load, ease triggering of
the ventilator, and reduce work of breathing [30, 31].
However, any benefit of PEEPe during controlled ventila-
tion is much less obvious [4], as underlined in a recent
publication [19] and as demonstrated in various studies
[8, 11, 32]. In a study using the MIGET in COPD patients
during controlled ventilation, Rossi et al. [8] showed that
when PEEPe at 50% of measured PEEPi was applied, no
change in respiratory mechanics was noted, while PaO2
increased as a result of a rise in the mean value of the dis-
tribution of perfusion. However, when PEEPe equivalent
to 100% of PEEPi was applied, airway pressures rose,
and no further improvement in gas exchange was noted
[8]. It should also be mentioned that no change in oxygen
transport was noted with the application pf PEEPe, while
reducing PEEPi through controlled hypoventilation in-
creased cardiac output and oxygen transport [8]. This
could have resulted from a reduction of the adverse he-
modynamic effects of PEEPi and could also be observed
when PEEPi is decreased by He/O2. However, we made
no such observation in our patients, probably because
there appeared to be little hemodynamic impact from PE-
EPi, as observed in a prior study [13]. Baigorri et al. [11]
showed that applying a PEEPe equal to measured PEEPi
led to an increase in end-expiratory volume, a rise in in-
trathoracic pressures, and no improvement in arterial
blood gases, while a decrease in cardiac output was noted
with a PEEPe exceeding PEEPi. Fernandez et al. [32] ob-
served that the increase in end-expiratory volume when
setting PEEPe equal to PEEPi was directly proportional
to respiratory system compliance, and hence that its mag-
nitude was difficult to predict in routine clinical condi-
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tions. The reasons for this lie in the fact that in the pres-
ence of expiratory flow limitation added increments of
PEEPe progressively replace PEEPi, without increasing
total PEEP and lung volume, until a critical value of
PEEPe is reached, above which total PEEP and lung vol-
ume both increase [33, 34]. When the latter occurs, in-
creased respiratory system elastance, decreased cardiac
output and worsening of gas exchange occur [34].
These various issues have led to the recommendation
of either refraining from using PEEPe in the presence of
PEEPi during controlled mechanical ventilation [19], or
to not exceed values of 50–85% of measured PEEPi,
while carefully monitoring the consequences of its appli-
cation [4]. In our study the goal was to apply a PEEPe
equivalent to 80% of PEEPi. However, it is difficult to as-
certain that this goal was always attained, since although
we used the PEEPi measured during the third step (air/O2
ZEEP 2), it is well known that PEEPi can change fairly
quickly [35]. Thus it is possible that PEEPe levels equal
to or exceeding PEEPi were applied in some patients, as
our results suggest. Indeed, as shown in Fig. 2, in most
patients PEEPi was replaced by PEEPe, but total PEEP
was mainly unchanged or even increased. This observa-
tion is in line with the studies cited above demonstrating
that, in the absence of expiratory flow limitation, or if ex-
cessive PEEPe levels are used even if such a limitation is
present, worsening dynamic hyperinflation and its com-
plications can occur. A seminal study by Tuxen [9] has il-
lustrated how severe the latter can be. Interestingly, in the
latter study, as overall lung volume and total PEEP in-
creased when high levels of PEEPe were applied, Vtrapped
decreased, most likely due to the rise in elastance and a
decrease in airway resistance associated with the higher
lung volume [9]. A similar observation was made in our
patients (Fig. 1), probably for identical reasons. Regard-
ing gas exchange, the blood gas and MIGET results
showed no effect of PEEPe, which is in apparent con-
tradiction with the improvement in PaO2 due to a higher
mean value of the perfusion distribution observed by
Rossi et al. [8]. However, those favorable effects oc-
curred at a lower PEEPe (50% of PEEPi), and disap-
peared when PEEPe was equal to PEEPi, which again
suggests excessive PEEPe levels in at least some of our
patients. These observations underline the difficulty of
correctly titrating PEEPe in this context. Having said this,
low levels of PEEPe (≤ 50% of PEEPi) may still be of
benefit, by preventing alveolar derecruitment, as shown
by the study by Rossi et al. [8].
In conclusion, the present study shows that in COPD
patients undergoing controlled mechanical ventilation,
with PEEPi, He/O2 can be a valuable approach to reduc-
ing dynamic hyperinflation/PEEPi, while only slightly
impairing arterial oxygenation due to a reduction in the
mean value of perfusion distribution. Conversely, PEEPe
can prove difficult to titrate and can induce worsening of
dynamic hyperinflation, the latter probably offsetting
any benefit of PEEPe on arterial oxygenation. Hence in
patients with severe and symptomatic dynamic hyperin-
flation, as can occur during the first few days of mechan-
ical ventilation, He/O2 could prove to be a valuable ap-
proach, provided the various technical issues associated
with its use are known by ICU physicians.
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